Start-Up Spotlight: Saluda Hopes To 'Evoke' From Down Under With First Closed-Loop Spine-Stim System
Aiming to improve the lives of patients living with chronic, intractable pain, Australian start-up Saluda Medical Pty Limited is the first and only neuromodulation company in the world to develop a closed-loop spinal cord stimulation system (SCS). Unlike other SCS systems marketed today, Saluda’s device, currently in clinical trials, is designed to measure the spinal cord’s response to electrical stimulation, and then respond to patient's preferred stimulation.
You may also be interested in...
Saluda Medical has secured funds from Medtronic and Boston Scientific to support the development of its spinal cord stimulation system for pain management.
Vagisil and BioFilm’s Astroglide “demonstrate very high levels of brand awareness, brand loyalty, and repeat purchase, and continue to attract new and younger consumers into the category,” firms say.
Nicotine mint lozenge approval for Perrigo; Lightbody for digital vision health; PLT has broad-spectrum immune health ingredient; Souvenaid for stronger synapses; Kinesiology tape for cellular oxygenation; Healthycell joint health and mobility gel; Nature’s Bounty Optimal Solutions hair, metabolism supplements; and Perricone extends vitamin c ester line.